Work

Anti‐thymocyte globulin in immune‐mediated cytopenias: A monocentric experience and literature review

Year: 2025

Type: article

Abstract: Anti-thymocyte globulin in multi-refractory immune-mediated cytopenia is an effective treatment, with response rate as high as 65%. Younger patients, presenting with thrombocytopenia or neutropenia, and those with LGL and STAT3 mutations appear to be more likely responsive.

Source: British Journal of Haematology

DOI: 10.1111/bjh.20165

Authors: Luca Guarnera, Arooj Ahmed, Carlos Bravo‐Perez, Olisaemeka D. Ogbue, Matteo D'Addona, Zachary Brady, Serhan Unlu, Christopher Haddad, Aashray Mandala, Arda Durmaz, Carmelo Gurnari, Valeria Visconte, Jaroslaw P. Maciejewski

Institutions: University of Rome Tor Vergata, Cleveland Clinic, Instituto de Salud Carlos III, Hospital General Universitario Morales Meseguer, Centre for Biomedical Network Research on Rare Diseases, Instituto Murciano de Investigación Biosanitaria, Universidad de Murcia

Language: English

Topic: Blood disorders and treatments

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $5,190

Funders: Aplastic Anemia and MDS International Foundation, Edward P. Evans Foundation, Instituto de Salud Carlos III

Award: G7611088543

OpenAlex ID: W4411295341

FWCI:

Cites: 14

Cited by:

Related to: 10